How to Image Hypertrophic Cardiomyopathy.
暂无分享,去创建一个
[1] M. Link,et al. Hypertrophic Cardiomyopathy With Left Ventricular Apical Aneurysm: Implications for Risk Stratification and Management. , 2017, Journal of the American College of Cardiology.
[2] B. Maron,et al. A Discussion of Contemporary Nomenclature, Diagnosis, Imaging, and Management of Patients With Hypertrophic Cardiomyopathy. , 2016, The American journal of cardiology.
[3] R. Chan,et al. Prognostic Value of LGE-CMR in HCM: A Meta-Analysis. , 2016, JACC. Cardiovascular imaging.
[4] L. Axel,et al. The Mitral Valve in Obstructive Hypertrophic Cardiomyopathy: A Test in Context. , 2016, Journal of the American College of Cardiology.
[5] M. Link,et al. Contemporary Natural History and Management of Nonobstructive Hypertrophic Cardiomyopathy. , 2016, Journal of the American College of Cardiology.
[6] W. Manning,et al. Significance of Late Gadolinium Enhancement at Right Ventricular Attachment to Ventricular Septum in Patients With Hypertrophic Cardiomyopathy. , 2015, The American journal of cardiology.
[7] N. Geller,et al. Hypertrophic Cardiomyopathy Registry: The rationale and design of an international, observational study of hypertrophic cardiomyopathy. , 2015, American heart journal.
[8] B. Maron,et al. Clinical Impact of Contemporary Cardiovascular Magnetic Resonance Imaging in Hypertrophic Cardiomyopathy , 2015, Circulation.
[9] N. Smedira,et al. Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy Patients Without Severe Septal Hypertrophy: Implications of Mitral Valve and Papillary Muscle Abnormalities Assessed Using Cardiac Magnetic Resonance and Echocardiography. , 2015, Circulation. Cardiovascular imaging.
[10] D. Kaye,et al. Histological validation of cardiac magnetic resonance analysis of regional and diffuse interstitial myocardial fibrosis. , 2015, European heart journal cardiovascular Imaging.
[11] Martin Borggrefe,et al. [2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy]. , 2014, Kardiologia polska.
[12] D. Bluemke,et al. Prediction of Sarcomere Mutations in Subclinical Hypertrophic Cardiomyopathy , 2014, Circulation. Cardiovascular imaging.
[13] K. Siminovitch,et al. Significance of left ventricular apical-basal muscle bundle identified by cardiovascular magnetic resonance imaging in patients with hypertrophic cardiomyopathy. , 2014, European heart journal.
[14] F. Rutten,et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). , 2014, European heart journal.
[15] E. Cook,et al. Prognostic Value of Quantitative Contrast-Enhanced Cardiovascular Magnetic Resonance for the Evaluation of Sudden Death Risk in Patients With Hypertrophic Cardiomyopathy , 2014, Circulation.
[16] Barry J Maron,et al. Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine. , 2014, Journal of the American College of Cardiology.
[17] B. Maron,et al. Left atrial remodeling in hypertrophic cardiomyopathy and susceptibility markers for atrial fibrillation identified by cardiovascular magnetic resonance. , 2014, The American journal of cardiology.
[18] D. Pennell,et al. Role of late gadolinium enhancement cardiovascular magnetic resonance in the risk stratification of hypertrophic cardiomyopathy , 2014, Heart.
[19] S. Colan,et al. Comparison of Echocardiographic and Cardiac Magnetic Resonance Imaging in Hypertrophic Cardiomyopathy Sarcomere Mutation Carriers Without Left Ventricular Hypertrophy , 2013, Circulation. Cardiovascular genetics.
[20] B. Maron,et al. Papillary muscle insertion directly into the anterior mitral leaflet in hypertrophic cardiomyopathy, its identification and cause of outflow obstruction by cardiac magnetic resonance imaging, and its surgical management. , 2013, The American journal of cardiology.
[21] Harry Rakowski,et al. Myocardial fibrosis in hypertrophic cardiomyopathy: accurate reflection of histopathological findings by CMR. , 2013, JACC. Cardiovascular imaging.
[22] R. Kwong,et al. T1 Measurements Identify Extracellular Volume Expansion in Hypertrophic Cardiomyopathy Sarcomere Mutation Carriers With and Without Left Ventricular Hypertrophy , 2013, Circulation. Cardiovascular imaging.
[23] S. K. White,et al. Identification and Assessment of Anderson-Fabry Disease by Cardiovascular Magnetic Resonance Noncontrast Myocardial T1 Mapping , 2013, Circulation. Cardiovascular imaging.
[24] Andrew S Flett,et al. Cardiovascular magnetic resonance measurement of myocardial extracellular volume in health and disease , 2012, Heart.
[25] Barry J Maron,et al. Genetics of hypertrophic cardiomyopathy after 20 years: clinical perspectives. , 2012, Journal of the American College of Cardiology.
[26] M. Maron,et al. Clinical Utility of Cardiovascular Magnetic Resonance in Hypertrophic Cardiomyopathy , 2012, Journal of Cardiovascular Magnetic Resonance.
[27] W. Manning,et al. Prevalence and Clinical Profile of Myocardial Crypts in Hypertrophic Cardiomyopathy , 2011, Circulation. Cardiovascular imaging.
[28] Barry J Maron,et al. 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines , 2011, Circulation.
[29] Vasken Dilsizian,et al. American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with hypertrophic cardiomyopathy: Endorsed by the American Society of Nuclear Cardiology, Society for Cardiovascular Magnetic Resonance, and Society of Cardiovascular Computed Tomograph , 2011, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[30] Vivek Muthurangu,et al. Evaluation of techniques for the quantification of myocardial scar of differing etiology using cardiac magnetic resonance. , 2011, JACC. Cardiovascular imaging.
[31] W. Manning,et al. Mitral valve abnormalities identified by cardiovascular magnetic resonance represent a primary phenotypic expression of hypertrophic cardiomyopathy , 2010, Circulation.
[32] B. Maron,et al. Timing and significance of exercise-induced left ventricular outflow tract pressure gradients in hypertrophic cardiomyopathy. , 2010, The American journal of cardiology.
[33] G. Boriani,et al. Prognostic implications of the Doppler restrictive filling pattern in hypertrophic cardiomyopathy. , 2009, The American journal of cardiology.
[34] M. Sherrid,et al. Resection-plication-release for hypertrophic cardiomyopathy: clinical and echocardiographic follow-up. , 2008, The Annals of thoracic surgery.
[35] Jeroen J. Bax,et al. Echocardiography in hypertrophic cardiomyopathy: the role of conventional and emerging technologies. , 2008, JACC. Cardiovascular imaging.
[36] Luigi Rega,et al. Assessment and significance of left ventricular mass by cardiovascular magnetic resonance in hypertrophic cardiomyopathy. , 2008, Journal of the American College of Cardiology.
[37] W. Manning,et al. Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. , 2008, Journal of the American College of Cardiology.
[38] M. Link,et al. Hypertrophic Cardiomyopathy Is Predominantly a Disease of Left Ventricular Outflow Tract Obstruction , 2008 .
[39] S. Ommen,et al. Evaluation of Left Ventricular Filling Pressures by Doppler Echocardiography in Patients With Hypertrophic Cardiomyopathy: Correlation With Direct Left Atrial Pressure Measurement at Cardiac Catheterization , 2007, Circulation.
[40] M. Robson,et al. Evidence for Microvascular Dysfunction in Hypertrophic Cardiomyopathy: New Insights From Multiparametric Magnetic Resonance Imaging , 2007, Circulation.
[41] S. Nagueh,et al. Noninvasive cardiac imaging in patients with hypertrophic cardiomyopathy. , 2006, Journal of the American College of Cardiology.
[42] B. Maron,et al. Prognostic significance of left atrial size in patients with hypertrophic cardiomyopathy (from the Italian Registry for Hypertrophic Cardiomyopathy). , 2006, The American journal of cardiology.
[43] W. Manning,et al. Prevalence, Clinical Profile, and Significance of Left Ventricular Remodeling in the End-Stage Phase of Hypertrophic Cardiomyopathy , 2006, Circulation.
[44] D. Pennell,et al. Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography , 2004, Heart.
[45] M. Quiñones,et al. Tissue Doppler Imaging Predicts the Development of Hypertrophic Cardiomyopathy in Subjects With Subclinical Disease , 2003, Circulation.
[46] D. Mozaffarian,et al. Right ventricular involvement in hypertrophic cardiomyopathy , 2001 .
[47] L. Faber,et al. Targeting percutaneous transluminal septal ablation for hypertrophic obstructive cardiomyopathy by intraprocedural echocardiographic monitoring. , 2000, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[48] B. Maron,et al. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. , 2000, The New England journal of medicine.
[49] M. Condorelli,et al. Exercise capacity in hypertrophic cardiomyopathy depends on left ventricular diastolic function. , 1999, The American journal of cardiology.
[50] B. Maron,et al. Utility of continuous wave Doppler echocardiography in the noninvasive assessment of left ventricular outflow tract pressure gradient in patients with hypertrophic cardiomyopathy. , 1992, Journal of the American College of Cardiology.